A Novel Tumor Suppressor SPINK5 Serves as an Independent Prognostic Predictor for Patients with Head and Neck Squamous Cell Carcinoma

BACKGROUND: In our previous study, serine protease inhibitor Kazal-type 5 (SPINK5), which encodes the product of serine protease inhibitor lymphoepithelial Kazal-type-related inhibitor (LEKTI) was found to be down-regulated in head and neck squamous cell carcinoma (HNSCC) using oligonucleotide micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Zhongjing, Wu, Kun, Qin, Xing, Yuan, Jian, Yan, Ming, Zhang, Jianjun, Wang, Lizhen, Ji, Tong, Cao, Wei, Chen, Wantao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320891/
https://www.ncbi.nlm.nih.gov/pubmed/32606974
http://dx.doi.org/10.2147/CMAR.S236266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320891/
https://www.ncbi.nlm.nih.gov/pubmed/32606974
http://dx.doi.org/10.2147/CMAR.S236266

Ejemplares similares